Distribution of IgG subclass antibodies specific for Plasmodium falciparum glutamate-rich-protein molecule in sickle cell trait children with asymptomatic infections

Experimental Parasitology

Volumn 112, Issue 2, 2006, Pages 92-98

  Matondo Maya, Davy W ^a   Mavoungou, Elie ^a,b   Deloron, Philippe ^c,d   Theisen, Michael ^e   Ntoumi, Francine ^a,b,d  

^a Hopital Albert Schweitzer   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

Antibodies; DNA, deoxyribonucleic acid; GLURP; GLURP, glutamate rich protein; Hb, hemoglobin; Malaria; P. falciparum, Plasmodium falciparum; Plasmodium falciparum; Sickle cell trait

Indexed keywords

BETA GLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN G; VIRUS ANTIGEN;

ALLELE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; DISEASE TRANSMISSION; DNA EXTRACTION; FEMALE; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PARASITE EXAMINATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SICKLE CELL TRAIT;

AGE DISTRIBUTION; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GABON; HEMOGLOBIN A; HEMOGLOBIN, SICKLE; HETEROZYGOTE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SEROEPIDEMIOLOGIC STUDIES; SEX RATIO; SICKLE CELL TRAIT;

PLASMODIUM FALCIPARUM;

EID: 30644463092     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2005.09.014     Document Type: Article

References (40)

1. N.H. Abdulhadi Protection against severe clinical manifestations of Plasmodium falciparum malaria among sickle cell trait subjects is due to modification of the release of cytokines and/or cytoadherence of infected erythrocytes to the host vascular beds Med. Hypotheses 60 2003 912 914
2. M. Aidoo, D.J. Terlouw, M.S. Kolczak, P.D. McElroy, F.O. ter Kuile, S. Kariuki, B.L. Nahlen, A.A. Lal, and V. Udhayakumar Protective effects of the sickle cell gene against malaria morbidity and mortality Lancet 359 2002 1311 1312
3. S.J. Allen, S. Bennett, E.M. Riley, P.A. Rowe, P.H. Jakobsen, A. O'Donnell, and B.M. Greenwood Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia Trans. R. Soc., Trop. Med. Hyg. 86 1992 494 498
4. S.J. Allen, A. O'Donnell, N.D. Alexander, M.P. Alpers, T.E. Peto, J.B. Clegg, and D.J. Weatherall Alpha+-Thalassemia protects children against disease caused by other infections as well as malaria Proc. Natl. Acad. Sci. USA 94 1997 14736 14741
5. A.C. Allison The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria Trans. R. Soc., Trop. Med. Hyg. 48 1954 312 318
6. C. Aucan, Y. Traore, F. Tall, B. Nacro, T. Traore-Leroux, F. Fumoux, and P. Rihet High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria Infect. Immun. 68 2000 1252 1258
7. M.B. Borre, M. Dziegiel, B. Hogh, E. Petersen, K. Rieneck, E. Riley, J.F. Meis, M. Aikawa, K. Nakamura, M. Harada, A. Wind, P.H. Jakobsen, J. Cowland, S. Jepsen, N.H. Axelsen, and J. Vuust Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle Mol. Biochem. Parasitol. 49 1991 119 131
8. H. Bouharoun-Tayoun, P. Attanath, A. Sabchareon, T. Chongsuphajaisiddhi, and P. Druilhe Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes J. Exp. Med. 172 1990 1633 1641
9. E.M. Braga, R.M. Barros, T.A. Reis, C.J. Fontes, C.G. Morais, M.S. Martins, and A.U. Krettli Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kDa) with clinical immunity to malaria in the Brazilian Amazon region Am. J. Trop. Med. Hyg. 66 2002 461 466
10. D.R. Cavanagh, D. Dodoo, L. Hviid, J.A. Kurtzhals, T.G. Theander, B.D. Akanmori, S. Polley, D.J. Conway, K. Koram, and J.S. McBride Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria Infect. Immun. 72 2004 6492 6502
11. J.P. Chippaux, A. Massougbodji, J.C. Boulard, and M. Akogbeto Morbidity and severity of malaria attacks in carriers of sickle-cell trait Rev. Epidemiol Sante Publique 40 1992 240 245
12. J.B. de Souza, J. Todd, G. Krishegowda, D.C. Gowda, D. Kwiatkowski, and E.M. Riley Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria Infect. Immun. 70 2002 5045 5051
13. D. Dodoo, M. Theisen, J.A. Kurtzhals, B.D. Akanmori, K.A. Koram, S. Jepsen, F.K. Nkrumah, T.G. Theander, and L. Hviid Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria J. Infect. Dis. 181 2000 1202 1205
14. P. Druilhe, and J.L. Perignon Mechanisms of defense against P. falciparum asexual blood stages in humans Immunol. Lett. 41 1994 115 120
15. M. Dziegiel, M.B. Borre, E. Petersen, B. Hogh, S. Jepsen, J. Vuust, and N. Axelsen Capture ELISA for IgM antibodies against Plasmodium falciparum glutamate rich protein J. Immunol. Methods 155 1992 207 213
16. N. Elissa, S. Karch, P. Bureau, B. Ollomo, M. Lawoko, P. Yangari, B. Ebang, and A.J. Georges Malaria transmission in a region of savanna-forest mosaic, Haut-Ogooue, Gabon J. Am. Mosq. Control Assoc. 15 1999 15 23
17. B. Genton, I. Betuela, I. Felger, F. Al-Yaman, R.F. Anders, A. Saul, L. Rare, M. Avizor, K. Lorry, G.V. Brown, D. Pye, D.O. Irving, T.A. Smith, H.P. Beck, and M.P. Alpers A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea J. Infect. Dis. 185 2002 820 827
18. A.V. Hill, C.E. Allsopp, D. Kwiatkowski, N.M. Anstey, P. Twumasi, P.A. Rowe, S. Bennett, D. Brewster, A.J. McMichael, and B.M. Greenwood Common West African HLA antigens are associated with protection from severe malaria Nature 352 1991 595 600
19. B. Hogh, R. Thompson, I.S. Zakiuddin, C. Boudin, and M. Borre Glutamate rich Plasmodium falciparum antigen (GLURP) Parassitologia 35 1993 47 50
20. P.H. Jakobsen, T.G. Theander, L. Hviid, S. Morris-Jones, J.B. Jensen, R.A. Bayoumi, B.M. Greenwood, I.C. Bygbjerg, and P.M. Heegaard Antibody reactivities to glutamate-rich peptides of Plasmodium falciparum parasites in humans from areas of different malaria endemicity APMIS 104 1996 734 740
21. K. Marsh, L. Otoo, R.J. Hayes, D.C. Carson, and B.M. Greenwood Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection Trans. R. Soc., Trop. Med. Hyg. 83 1989 293 303
22. V. Meraldi, I. Nebie, A.B. Tiono, D. Diallo, E. Sanogo, M. Theisen, P. Druilhe, G. Corradin, R. Moret, and B.S. Sirima Natural antibody response to Plasmodium falciparum Exp-1, MSP-3, and GLURP long synthetic peptides and association with protection Parasite Immunol. 26 2004 265 272
23. F. Migot-Nabias, L.E. Mombo, A.J. Luty, B. Dubois, R. Nabias, C. Bisseye, P. Millet, C.Y. Lu, and P. Deloron Human genetic factors related to susceptibility to mild malaria in Gabon Genes Immun. 1 2000 435 1441
24. L.H. Miller Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans Proc. Natl. Acad. Sci. USA 91 1994 2415 2419
25. R.L. Nagel, R.M. Bookchin, J. Johnson, D. Labie, H. Wajcman, W.A. Isaac-Sodeye, G.R. Honig, G. Schiliro, J.H. Crookston, and K. Matsutomo Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S Proc. Natl. Acad. Sci. USA 76 1979 670 672
26. F. Ntoumi, M.T. Ekala, M. Makuwa, F. Lekoulou, O. Mercereau-Puijalon, and P. Deloron Sickle cell trait carriage: imbalanced distribution of IgG subclass antibodies reactive to Plasmodium falciparum family-specific MSP2 peptides in serum samples from Gabonese children Immunol. Lett. 84 2002 9 16
27. J.O. Odegbemi, and A.I. Williams Immunoglobulin levels in malaria infected Nigerians with and without abnormal haemoglobin Afr. J. Med. Med. Sci. 24 1995 21 25
28. J.L. Perignon, and P. Druilhe Immune mechanisms underlying the premunition against Plasmodium falciparum malaria Mem. Inst. Oswaldo Cruz 89 Suppl. 2 1994 51 53
29. R. Perraut, L. Marrama, B. Diouf, D. Fontenille, A. Tall, C. Sokhna, J.F. Trape, O. Garraud, and O. Mercereau-Puijalon Distinct surrogate markers for protection against Plasmodium falciparum infection and clinical malaria identified in a Senegalese community after radical drug cure J. Infect. Dis. 188 2003 1940 1950
30. E. Petersen, B. Hogh, M. Dziegiel, M. Borre, A. Bjorkman, N.T. Marbiah, E. Dolopaye, A.P. Hanson, and S. Jepsen The antibody response to well-defined malaria antigens after acute malaria in individuals living under continuous malaria transmission Acta Trop. 51 1992 135 142
31. P. Rihet, L. Flori, F. Tall, A.S. Traore, and F. Fumoux Hemoglobin C is associated with reduced Plasmodium falciparum parasitemia and low risk of mild malaria attack Hum. Mol. Genet. 13 2004 1 6
32. E.M. Riley, S.J. Allen, J.G. Wheeler, M.J. Blackman, S. Bennett, B. Takacs, H.J. Schonfeld, A.A. Holder, and B.M. Greenwood Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity Parasite Immunol. 14 1992 321 337
33. R.W. Snow, M. Craig, U. Deichmann, and K. Marsh Estimating mortality, morbidity, and disability due to malaria among Africa's non pregnant population Bull. World Health Organ. 77 1999 624 640
34. S. Soe, M. Theisen, C. Roussilhon, K.S. Aye, and P. Druilhe Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein Infect. Immun. 72 2004 247 252
35. R.R. Taylor, S.J. Allen, B.M. Greenwood, and E.M. Riley IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria Am. J. Trop. Med. Hyg. 58 1998 406 413
36. M. Theisen, D. Dodoo, A. Toure-Balde, S. Soe, G. Corradin, K.K. Koram, J.A. Kurtzhals, L. Hviid, T. Theander, B. Akanmori, M. Ndiaye, and P. Druilhe Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity Infect. Immun. 69 2001 5223 5229
37. M. Theisen, S. Soe, C. Oeuvray, A.W. Thomas, J. Vuust, S. Danielsen, S. Jepsen, and P. Druilhe The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro Infect. Immun. 66 1998 11 17
38. M. Theisen, J. Vuust, A. Gottschau, S. Jepsen, and B. Hogh Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli Clin. Diagn. Lab. Immunol. 2 1995 30 34
39. T.N. Williams, T.W. Mwangui, S. Wambua, N.D. Alexander, M. Kortok, R.W. Snow, and K. Marsh Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases J. infect. Dis. 192 2005 178 186
40. D.Y. Wu, L. Ugozzoli, B.K. Pal, and R.B. Wallace Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia Proc. Natl. Acad. Sci. USA 86 1989 2757 2760